Our product cures!
Let's see how this plays out.
Do you think everyone in the world will vaccinate themselves?
I think not.
There's not that much money to be made in it for the drug companies.
Vaccines have never proven to be beneficial to the drug companies. That's why, if I'm not mistaken, almost all drug companies have dropped manufacturing and researching vaccines, All except one (unfortunately I forgot which one. It is a US company).
Nothing tells the truth as much as seeing what's happening on the tape.
When buying pressure surfaces and prices begin to spike, you know 100% that someone influential is taking a stake.
The proof is in the pudding.
Very strong bid at 16.55
Wouldn't surprise me if it's Frost, scooping up a little more for his holdings.
They have accepted the application for review. All that remains is approval.
OPKO Health, Inc. (OPK) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review OPKO’s New Drug Application (NDA) for calcifediol modified-release capsules (proposed trade name, Rayaldee™). In the NDA, OPKO seeks approval of Rayaldee.
“FDA acceptance of this NDA should be cheered by healthcare professionals who care for CKD patients,” commented Dr. Kevin J. Martin, Director of the Division of Nephrology at Saint Louis University School of Medicine. “If approved, Rayaldee will provide a new therapeutic option for controlling elevated parathyroid hormone levels in this large and undertreated patient population.”
It's one thing to do a secondary to covering normal operating costs,
it's another to fund something in the pipeline.
We'll go higher.
OPKO expects written notification of NDA acceptance along with the Prescription Drug User Fee Act (PDUFA) date in the FDA’s 74-Day letter, which the Company expects to receive by mid-August 2015.
I'm salivating over the cross selling potential of Auxilio's client base and Redspin's client base and their aggressive maneuvers to capture Healthcare Security issues.
Boy do you have a lot to learn.
You think Nokia with 500 million shares would command the same price as with 3 billion shares, then you have to rethink.
Let's hope they plow the entire amount into share buybacks.
The don't need the cash and it will offset the share issuance next year for the ALU purchase.
$8 billion in cash on hand and about $1.2 billion in free cash flow every year.
Get the stock price higher. Happy investors, happy pension funds, more leverage in future expansion.
I'd be cautious here with all the legal entanglements.
Usually, not always, where there's smoke, there's fire.
No need to chase here. Wait for the smoke to clear.
If they're good, they'll be around for a long time.
Just hate stepping back in at 9 or 10 and then have it plunge again to 4.
I'd rather wait.
You are so right.
There are many analysts who are friends of mine that have said the same thing.
Stay away. Don't even write for them!
AEMD allowed to withhold highly classified information from their reporting.
Results from government projects could potentially be groundbreaking!
I can only surmise as much.